REYATAZ Side Effects

6923869-5 | Dyspepsia
on Jan 29, 2010 Male patient from UNITED STATES , 23 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: dyspepsia. Reyataz dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), NORVIR (View Norvir Review and Norvir Label ).

6923868-3 | Hepatic Function Abnormal, Renal Impairment
Patient was taking Reyataz (View Usage). Patient had the following side effects: hepatic function abnormal, renal impairment on Jan 28, 2010 from UNITED STATES Additional patient health information: Male patient , 39 years of age, weighting 216.1 lb, was diagnosed with hiv infection (What is hiv infection?) and. Reyataz dosage: 4-5 Months. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ).

6923862-2 | Anaemia
Adverse event was reported on Dec 15, 2009 by a Male patient taking Reyataz (View Usage) (Dosage: ) . Location: UNITED STATES , 21 years of age, After Reyataz was administered, patient had the following side effects: anaemia. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6923861-0 | Nephrolithiasis
on Dec 14, 2009 Male patient from UNITED STATES , 50 years of age, weighting 209.4 lb, was diagnosed with hiv infection (What is hiv infection?), hypertension and was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: nephrolithiasis. Reyataz dosage: . During the same period patient was treated with ZIAGEN (1df=600 Unit Nos) (View Ziagen Review and Ziagen Label ), NORVIR (1 Df=100 Unit Nos) (View Norvir Review and Norvir Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), CELEXA (View Celexa Review and Celexa Label ), WELLBUTRIN XL (1 Df=300x2) (View Wellbutrin Xl Review and Wellbutrin Xl Label ), VIREAD (1df=300 Unit Nos) (View Viread Review and Viread Label ). Patient was hospitalized.


6923856-7 | Arrhythmia
on Nov 06, 2009 Male patient from UNITED STATES , 30 years of age, was treated with Reyataz (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?). Reyataz dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), TRUVADA (View Truvada Review and Truvada Label ).

6923855-5 | Nephrolithiasis
Patient was taking Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: nephrolithiasis on Oct 26, 2009 from UNITED STATES Additional patient health information: Female patient , 21 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Reyataz dosage: . Patient was hospitalized.

6923854-3 | Hyperbilirubinaemia
Adverse event was reported on Oct 23, 2009 by a Male patient taking Reyataz (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 62 years of age, Patient experienced the following unwanted or unexpected effects: hyperbilirubinaemia. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), DAPSONE (View Dapsone Review and Dapsone Label ), NPLATE (View Nplate Review and Nplate Label ).

6923850-6 | Live Birth, Pregnancy
on Nov 18, 2009 Female patient from UNITED STATES , 32 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient had the following side effects: live birth, pregnancy (What is pregnancy?). Reyataz dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), EPZICOM (1 Df - 1tabs) (View Epzicom Review and Epzicom Label ).

6923849-X | Nephrolithiasis
on Oct 21, 2009 Male patient from UNITED STATES , 42 years of age, was diagnosed with hiv test positive (What is hiv test positive?) and was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: nephrolithiasis. Reyataz dosage: .

6923848-8 | Blood Bilirubin Increased
Patient was taking Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased on Oct 05, 2009 from UNITED STATES Additional patient health information: Male patient , 44 years of age, . Reyataz dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), TRUVADA (View Truvada Review and Truvada Label ).

6923842-7 | Rash
Adverse event was reported on Sep 15, 2009 by a Male patient taking Reyataz (View Usage) (Dosage: Less Than 2 Weeks) . Location: UNITED STATES , 34 years of age, Patient had the following side effects: rash (What is rash?). During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6923841-5 | Influenza Like Illness, Lipodystrophy Acquired, Neuralgia
on Sep 08, 2009 Male patient from UNITED STATES , 54 years of age, weighting 244.7 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: influenza like illness, lipodystrophy acquired, neuralgia. Reyataz dosage: Initial Dose 200 Mg Qd; Taken For About 17 Months.. During the same period patient was treated with VIRAMUNE (View Viramune Review and Viramune Label ), TRIZIVIR (View Trizivir Review and Trizivir Label ), AVAPRO (View Avapro Review and Avapro Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6923840-3 | Blood Bilirubin Increased
on Sep 09, 2009 Male patient from UNITED STATES , 73 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased. Reyataz dosage: Boosted. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), NORVIR (View Norvir Review and Norvir Label ), CRANBERRY JUICE (View Cranberry Juice Review and Cranberry Juice Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), CHONDROITIN SULFATE + GLUCOSAMINE (View Chondroitin Sulfate + Glucosamine Review and Chondroitin Sulfate + Glucosamine Label ).

6923831-2 | Blood Bilirubin Unconjugated Increased
Patient was taking Reyataz (View Usage). Patient had the following side effects: blood bilirubin unconjugated increased on Aug 26, 2009 from UNITED STATES Additional patient health information: Female patient , 13 years of age, . Reyataz dosage: .

6923830-0 | Diarrhoea, Migraine, Proctalgia
Adverse event was reported on Aug 22, 2009 by a Male patient taking Reyataz (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 43 years of age, weighting 185.2 lb, After Reyataz was administered, patient had the following side effects: diarrhoea, migraine (What is migraine?), proctalgia. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), BACTRIM (View Bactrim Review and Bactrim Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), ELAVIL (View Elavil Review and Elavil Label ), PERCOCET (View Percocet Review and Percocet Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

6923829-4 | Calculus Ureteric
on Sep 22, 2009 Male patient from UNITED STATES , 36 years of age, weighting 152.1 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: calculus ureteric. Reyataz dosage: . During the same period patient was treated with MARAVIROC (View Maraviroc Review and Maraviroc Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6923827-0 | Nephrolithiasis
on Aug 05, 2009 Male patient from UNITED STATES , 48 years of age, was treated with Reyataz (View Usage). Patient had the following side effects: nephrolithiasis. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), VIRAMUNE (View Viramune Review and Viramune Label ), ISENTRESS (View Isentress Review and Isentress Label ).

6923826-9 | Thrombocytopenia
Patient was taking Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: thrombocytopenia on Jul 30, 2009 from UNITED STATES Additional patient health information: Male patient , 36 years of age, weighting 152.1 lb, was diagnosed with hiv infection (What is hiv infection?) and. Reyataz dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), PREDNISONE (1df-20-30mg Alternating Daily) (View Prednisone Review and Prednisone Label ), DESIPRAMINE HCL (View Desipramine Hcl Review and Desipramine Hcl Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ).

6923825-7 | Creatinine Renal Clearance Decreased
Adverse event was reported on Jul 29, 2009 by a Male patient taking Reyataz (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 65 years of age, Patient experienced the following unwanted or unexpected effects: creatinine renal clearance decreased. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ).

6923822-1 | Hyperbilirubinaemia
on Jul 21, 2009 Male patient from UNITED STATES , 45 years of age, was treated with Reyataz (View Usage). Patient had the following side effects: hyperbilirubinaemia. Reyataz dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ).

6920622-3 | Depression, Haematuria, Nephrolithiasis, Peripheral Sensory Neuropathy, Suicidal Ideation
on Aug 06, 2010 Male patient from FRANCE , 35 years of age, weighting 185.2 lb, was diagnosed with tobacco abuse and was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: depression (What is depression?), haematuria, nephrolithiasis, peripheral sensory neuropathy, suicidal ideation. Reyataz dosage: One Intake Daily. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (One Intake Daily) (View Truvada Review and Truvada Label ), CHAMPIX (View Champix Review and Champix Label ). Patient was hospitalized.

6918948-2 | Hyperbilirubinaemia
Patient was taking Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: hyperbilirubinaemia on Aug 05, 2010 from COLOMBIA Additional patient health information: Male patient , 32 years of age, . Reyataz dosage: Reyataz 300. During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6914769-5 | Liver Disorder, Portal Hypertension
Adverse event was reported on Aug 03, 2010 by a Male patient taking Reyataz (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 61 years of age, Patient had the following side effects: liver disorder, portal hypertension. During the same period patient was treated with VIDEX (Capsule) (View Videx Review and Videx Label ), ZIAGEN (Tabs) (View Ziagen Review and Ziagen Label ), NORVIR (View Norvir Review and Norvir Label ). Patient was hospitalized.

6914123-6 | Peripheral Ischaemia, Polyneuropathy
on Aug 04, 2010 Male patient from ARGENTINA , 38 years of age, was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: peripheral ischaemia, polyneuropathy. Reyataz dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ). Patient was hospitalized.

6913968-6 | Renal Colic
on Aug 05, 2010 Male patient from FRANCE , 45 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: renal colic. Reyataz dosage: 1 Df - 1 Caps. During the same period patient was treated with NORVIR (Norvir (ritonavir) 100 Mg ;1 Df - 1 Caps;) (View Norvir Review and Norvir Label ), ABACAVIR SULFATE AND LAMIVUDINE (Kivexa (abacavir, Lamivudine) 600 Mg/300 Mg;1 Df - 1 Tabs) (View Abacavir Sulfate And Lamivudine Review and Abacavir Sulfate And Lamivudine Label ). Patient was hospitalized.

6909066-8 | Nephrolithiasis, Sepsis
Patient was taking Reyataz (View Usage). Patient had the following side effects: nephrolithiasis, sepsis (What is sepsis?) on Jul 29, 2010 from BRAZIL Additional patient health information: Female patient , 46 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Reyataz dosage: . During the same period patient was treated with BIOVIR (View Biovir Review and Biovir Label ), KALETRA (View Kaletra Review and Kaletra Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized.

6906264-4 | Viral Load Increased
Adverse event was reported on Jul 28, 2010 by a Male patient taking Reyataz (View Usage) (Dosage: ) . Location: FRANCE , 45 years of age, After Reyataz was administered, patient had the following side effects: viral load increased.

6905700-7 | Renal Colic
on Jul 29, 2010 Male patient from FRANCE , 45 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: renal colic. Reyataz dosage: 1 Df - 1 Caps. During the same period patient was treated with NORVIR (Norvir (ritonavir) 100 Mg ;1 Df - 1 Caps;) (View Norvir Review and Norvir Label ), ABACAVIR SULFATE AND LAMIVUDINE (Kivexa (abacavir, Lamivudine) 600 Mg/300 Mg;1 Df - 1 Tabs) (View Abacavir Sulfate And Lamivudine Review and Abacavir Sulfate And Lamivudine Label ). Patient was hospitalized.

6900747-9 | Dehydration, Haematocrit Decreased, Renal Failure
on Jul 27, 2010 Male patient from UNITED STATES , 41 years of age, weighting 112.4 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient had the following side effects: dehydration, haematocrit decreased, renal failure. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), DAPSONE (View Dapsone Review and Dapsone Label ), LAMISIL (View Lamisil Review and Lamisil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6895604-0 | Anaphylactic Reaction
Patient was taking Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: anaphylactic reaction on Jul 27, 2010 from UNITED STATES Additional patient health information: Male patient , 59 years of age, . Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ).

6880809-5 | Glaucoma, Hypokalaemia, Hyponatraemia, Renal Impairment, Uveitis
Adverse event was reported on Jul 20, 2010 by a Male patient taking Reyataz (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), cytomegalovirus viraemia, opportunistic infection prophylaxis and. Location: JAPAN , 58 years of age, Patient experienced the following unwanted or unexpected effects: glaucoma (What is glaucoma?), hypokalaemia, hyponatraemia, renal impairment, uveitis. During the same period patient was treated with STOCRIN (Last Administration On 12-jun-2007.) (View Stocrin Review and Stocrin Label ), NORVIR (View Norvir Review and Norvir Label ), TRUVADA (1 Dosage Form = 1 Tablet Per Day, Every Other Day.) (View Truvada Review and Truvada Label ), FOSCAVIR (11mar07 To 10jun07 92days; 26jun07 To 10jul07 15days 2.4mg/kg Bid) (View Foscavir Review and Foscavir Label ), ZITHROMAC (7feb07 - 30may07 600mg/d; 12jun07 - Unk 600mg/wk) (View Zithromac Review and Zithromac Label ), EPZICOM (1 Dosage Form = 1 Tablet.last Administration On 14-jun-2007.) (View Epzicom Review and Epzicom Label ), ITRACONAZOLE (12jun07 - 11jul07, 12jul - Unk) (View Itraconazole Review and Itraconazole Label ), MICAFUNGIN SODIUM (View Micafungin Sodium Review and Micafungin Sodium Label ). Patient was hospitalized.

6867403-7 | Dehydration, Renal Failure
on Jul 20, 2010 Male patient from UNITED STATES , 41 years of age, weighting 112.4 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient had the following side effects: dehydration, renal failure. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ). Patient was hospitalized.

6856022-4 | Anxiety
on Jul 14, 2010 Female patient from UNITED STATES , 26 years of age, was diagnosed with hiv infection (What is hiv infection?), headache (What is headache?) and was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: anxiety (What is anxiety?). Reyataz dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), PANADO (View Panado Review and Panado Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), ADCO DOL (View Adco-dol Review and Adco-dol Label ), CALCIUM + VITAMIN D (View Calcium + Vitamin D Review and Calcium + Vitamin D Label ), VITAMIN C (View Vitamin C Review and Vitamin C Label ). Patient was hospitalized.

6844742-7 | Abortion Spontaneous, Pregnancy
Patient was taking Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous, pregnancy (What is pregnancy?) on Jul 12, 2010 from UNITED STATES Additional patient health information: Female patient , 27 years of age, . Reyataz dosage: Course:1, Tab. During the same period patient was treated with NORVIR (Course:1) (View Norvir Review and Norvir Label ), TRUVADA (Course:1 1df:1 Unit Nos) (View Truvada Review and Truvada Label ).

6839679-3 | Diabetes Mellitus, Dizziness, Dyspnoea, Face Oedema, Influenza Like Illness, Jaundice, Paraesthesia, Stomatitis
Adverse event was reported on Jul 07, 2010 by a Female patient taking Reyataz (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 38 years of age, weighting 235.9 lb, Patient had the following side effects: diabetes mellitus, dizziness (What is dizziness?), dyspnoea, face oedema, influenza like illness, jaundice (What is jaundice?), paraesthesia, stomatitis. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRICOR (View Tricor Review and Tricor Label ), DULCOLAX (View Dulcolax Review and Dulcolax Label ), BUSPIRONE (View Buspirone Review and Buspirone Label ), TRUVADA (View Truvada Review and Truvada Label ), WELLBUTRIN XL (View Wellbutrin Xl Review and Wellbutrin Xl Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), LYRICA (View Lyrica Review and Lyrica Label ).

6839672-0 | Psychotic Disorder, Somnolence
on Jul 07, 2010 Female patient from UNITED STATES , 45 years of age, was diagnosed with hiv infection (What is hiv infection?), psychotic disorder (What is psychotic disorder?), parkinson's disease (What is parkinson's disease?), irritability, insomnia and was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: psychotic disorder (What is psychotic disorder?), somnolence. Reyataz dosage: . During the same period patient was treated with STOCRIN (View Stocrin Review and Stocrin Label ), COMBIVIR (19-oct-2009 To 12-feb-2010 And From 12-feb-2010 To 18-feb-2010 And Also From 10feb-18-feb-2010-cont) (View Combivir Review and Combivir Label ), EPIVIR (View Epivir Review and Epivir Label ), RETROVIR (View Retrovir Review and Retrovir Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

6819678-8 | Cholelithiasis, Pancreatitis Necrotising
on Jun 29, 2010 Male patient from FRANCE , 46 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: cholelithiasis, pancreatitis necrotising. Reyataz dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), NORVIR (View Norvir Review and Norvir Label ), CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.

6818852-4 | Caesarean Section, Normal Newborn, Pregnancy
Patient was taking Reyataz (View Usage). Patient had the following side effects: caesarean section, normal newborn, pregnancy (What is pregnancy?) on Jun 30, 2010 from IRELAND Additional patient health information: Female patient , 20 years of age, weighting 145.5 lb, was diagnosed with hiv infection (What is hiv infection?) and. Reyataz dosage: 300mg From 25jun09-14aug09, 600mg 14-aug-2009 To 28-aug-2009 400mg 28aug09-4sep09.. During the same period patient was treated with TRUVADA (1 Df - 1 Tabs) (View Truvada Review and Truvada Label ), NORVIR (View Norvir Review and Norvir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ).

6816907-1 | Caesarean Section, Live Birth, Pregnancy
Adverse event was reported on Jun 30, 2010 by a Female patient taking Reyataz (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: IRELAND , 30 years of age, weighting 216.1 lb, After Reyataz was administered, patient had the following side effects: caesarean section, live birth, pregnancy (What is pregnancy?). During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), EPZICOM (1df:1tabs) (View Epzicom Review and Epzicom Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), HEROIN (View Heroin Review and Heroin Label ).

6814408-8 | Diabetes Mellitus, Dizziness, Dyspnoea, Face Oedema, Influenza Like Illness, Jaundice, Paraesthesia, Stomatitis
on Jun 25, 2010 Female patient from UNITED STATES , 38 years of age, weighting 235.9 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus, dizziness (What is dizziness?), dyspnoea, face oedema, influenza like illness, jaundice (What is jaundice?), paraesthesia, stomatitis. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), TRICOR (View Tricor Review and Tricor Label ), DULCOLAX (View Dulcolax Review and Dulcolax Label ), BUSPIRONE HCL (View Buspirone Hcl Review and Buspirone Hcl Label ).

6794747-X | Staphylococcal Infection
on Jun 16, 2010 Female patient from FRANCE , 32 years of age, was diagnosed with hiv infection (What is hiv infection?), toxoplasmosis and was treated with Reyataz (View Usage). Patient had the following side effects: staphylococcal infection (What is staphylococcal infection?). Reyataz dosage: . During the same period patient was treated with ISENTRESS (View Isentress Review and Isentress Label ), TRUVADA (1 Df:200mg/245mg) (View Truvada Review and Truvada Label ), MALOCIDE (View Malocide Review and Malocide Label ), ADIAZINE (View Adiazine Review and Adiazine Label ), CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ). Patient was hospitalized.

6790268-9 | Normal Newborn, Pregnancy
Patient was taking Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: normal newborn, pregnancy (What is pregnancy?) on Jun 21, 2010 from FRANCE Additional patient health information: Female patient , 39 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Reyataz dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), KIVEXA (View Kivexa Review and Kivexa Label ), KALETRA (View Kaletra Review and Kaletra Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6784510-8 | Brain Oedema, Headache, Malignant Hypertension
Adverse event was reported on Jun 18, 2010 by a Female patient taking Reyataz (View Usage) (Dosage: 1df-300 Units Not Mentioned) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED KINGDOM , 29 years of age, Patient experienced the following unwanted or unexpected effects: brain oedema, headache (What is headache?), malignant hypertension. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), TENOFOVIR DF (View Tenofovir Df Review and Tenofovir Df Label ), ABACAVIR (View Abacavir Review and Abacavir Label ). Patient was hospitalized.

6784508-X | Brain Oedema, Headache
on Jun 18, 2010 Female patient from UNITED KINGDOM , 29 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). Patient had the following side effects: brain oedema, headache (What is headache?). Reyataz dosage: Reyataz Tablets 300mg. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), TENOFOVIR DF (View Tenofovir Df Review and Tenofovir Df Label ), ABACAVIR (View Abacavir Review and Abacavir Label ). Patient was hospitalized.

6782293-9 | Lipodystrophy Acquired
on Jun 14, 2010 Male patient from FRANCE , 73 years of age, weighting 138.9 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: lipodystrophy acquired. Reyataz dosage: . During the same period patient was treated with ISENTRESS (Tabs) (View Isentress Review and Isentress Label ).

6779132-9 | Arrhythmia, Confusional State, Coordination Abnormal, Dizziness, Memory Impairment
Patient was taking Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), confusional state, coordination abnormal, dizziness (What is dizziness?), memory impairment on Jun 14, 2010 from BRAZIL Additional patient health information: Female patient , 46 years of age, weighting 198.4 lb, was diagnosed with hiv infection (What is hiv infection?), bipolar disorder (What is bipolar disorder?), hypersensitivity and. Reyataz dosage: One Oral Capsule. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), TOPAMAX (View Topamax Review and Topamax Label ), HIXIZINE (View Hixizine Review and Hixizine Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ).

6772822-3 | Abortion Spontaneous, Pregnancy
Adverse event was reported on Jun 10, 2010 by a Female patient taking Reyataz (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 19 years of age, Patient had the following side effects: abortion spontaneous, pregnancy (What is pregnancy?). During the same period patient was treated with EPZICOM (1 Df = 1 Tab/cap) (View Epzicom Review and Epzicom Label ), NORVIR (View Norvir Review and Norvir Label ).

6772821-1 | Abortion Spontaneous, Pregnancy
on Jun 09, 2010 Female patient from UNITED STATES , 41 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Reyataz (View Usage). After Reyataz was administered, patient had the following side effects: abortion spontaneous, pregnancy (What is pregnancy?). Reyataz dosage: . During the same period patient was treated with EPZICOM (1 Df = 1 Tab/cap) (View Epzicom Review and Epzicom Label ).

6771350-9 | Renal Colic
on Jun 10, 2010 Female patient from FRANCE , 45 years of age, was treated with Reyataz (View Usage). Patient experienced the following unwanted or unexpected effects: renal colic. Reyataz dosage: . During the same period patient was treated with TRUVADA (1 Df = 1 Tablet) (View Truvada Review and Truvada Label ), NORVIR (View Norvir Review and Norvir Label ). Patient was hospitalized.

6769453-8 | Bile Duct Stone, Cholecystitis Acute, Cholelithiasis, Hepatitis Cholestatic
Patient was taking Reyataz (View Usage). Patient had the following side effects: bile duct stone, cholecystitis acute, cholelithiasis, hepatitis cholestatic on Jun 10, 2010 from CANADA Additional patient health information: Female patient , 47 years of age, weighting 202.8 lb, was diagnosed with hiv infection (What is hiv infection?), tuberculosis (What is tuberculosis?) and. Reyataz dosage: . During the same period patient was treated with ABACAVIR SULFATE/LAMIVUDINE (1 Df=600/300mg) (View Abacavir Sulfate/lamivudine Review and Abacavir Sulfate/lamivudine Label ), EFFEXOR (Extended-release Venlafaxine) (View Effexor Review and Effexor Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), AMITRIPTYLINE HCL (40 Mg At Bedtime) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ). Patient was hospitalized.